EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Potential role of ochratoxin A in Parkinson’s disease: a systematic review of current evidence

M Serrano-Civantos, E Beraza, L Álvarez-Erviti, A López de Cerain, A Vettorazzi iD

Archives of Toxicology · 2025-05 · 99 (5) · 1769-1790

DOI: 10.1007/s00204-025-03994-5 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Archives of Toxicology, online erschienen am 06.03.2025. Verfasst von M Serrano-Civantos und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, MITOX Research Group, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain. Hauptthemen laut MEDLINE: Ochratoxins, Parkinson Disease. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Departamento de Salud, Gobierno de Navarra, Instituto de Salud Carlos III, Ministerio de Universidades.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ochratoxin A (OTA) is a mycotoxin produced by Aspergillus and Penicillium species that contaminates various food and feed products, presenting potential risks to human health. While OTA is well-known for its nephrotoxic effects, emerging evidence highlights its neurotoxic potential. Parkinson’s disease (PD) is a neurodegenerative disorder with both genetic and environmental aetiologies. Emerging lines of investigation have focused their research on the role of environmental toxins, including mycotoxins, in PD pathogenesis. However, the specific involvement of OTA in PD-related pathways still needs to be unravelled. This systematic review compiles and evaluates OTA neurotoxicity studies according to the adverse outcome pathway (AOP) for PD, established by the Organisation for Economic Cooperation and Development (OECD). The AOP framework outlines a series of key event (KEs) beginning with mitochondrial Complex I (CI) inhibition and progressing through mitochondrial dysfunction, impaired proteostasis, dopaminergic neuron degeneration, neuroinflammation, and resulting in parkinsonian motor deficits. In this systematic review, a comprehensive literature search was conducted in PubMed, to identify studies evaluating OTA neurotoxic effects. Using a search strategy of 19 terms and following a two-phased study selection, 30 relevant studies were retrieved, of which 16 dealt with in vitro adult neurotoxicity (ANT), 13 focused on in vivo ANT, and 1 gave both in vitro and in vivo approaches. Authors agree that in vitro and in vivo exposure to OTA causes mitochondrial dysfunction, impaired proteostasis, degeneration of dopaminergic (DA) neurons, and neuroinflammation. However, a notable absence of research remains on the molecular initiating event (MIE), binding to CI, and on KE1, inhibition of CI. This review identifies critical research gaps and highlights the need for further mechanistic studies on the impact of OTA on neurodegenerative pathways, particularly its binding and inhibition of CI, as well as mechanisms related to KE3: impaired proteostasis. Addressing these gaps may provide valuable insights into OTA neurotoxic potential and its relevance in PD-like neurodegeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OchratoxinsParkinson DiseaseHumansAnimalsMycotoxinsNeurotoxicity Syndromes

Stichwörter der Autor:innen

Adverse outcome pathwayNeurodegenerationNeurotoxicityOchratoxinParkinson’s disease

Substanzen

Ochratoxinsochratoxin AMycotoxins

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, MITOX Research Group, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain.
  • Laboratory of Molecular Neurobiology, Center for Biomedical Research of La Rioja (CIBIR), Piqueras 98, 26006, Logroño, Spain.
  • Department of Pharmaceutical Sciences, MITOX Research Group, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain. avettora@unav.es.

ORCID-Profile: A Vettorazzi

Förderung

  • Departamento de Salud, Gobierno de Navarra
  • Instituto de Salud Carlos III
  • Ministerio de Universidades
  • Asociación de Amigos de la Universidad de Navarra
  • Universidad de Navarra

Zitieren

APA

Serrano-Civantos, M., Beraza, E., Álvarez-Erviti, L., de Cerain, A. L., & Vettorazzi, A. (2025). Potential role of ochratoxin A in Parkinson’s disease: a systematic review of current evidence. Archives of Toxicology, 99(5), 1769-1790. https://doi.org/10.1007/s00204-025-03994-5

Vancouver

Serrano-Civantos M, Beraza E, Álvarez-Erviti L, de Cerain AL, Vettorazzi A. Potential role of ochratoxin A in Parkinson’s disease: a systematic review of current evidence. Archives of Toxicology. 2025;99(5):1769-1790. doi:10.1007/s00204-025-03994-5

BibTeX
@article{SerranoCivantos2025,
  author = {Serrano-Civantos, M and Beraza, E and Álvarez-Erviti, L and de Cerain, A López and Vettorazzi, A},
  title = {Potential role of ochratoxin A in Parkinson’s disease: a systematic review of current evidence},
  journal = {Archives of Toxicology},
  year = {2025},
  volume = {99},
  number = {5},
  pages = {1769--1790},
  doi = {10.1007/s00204-025-03994-5}
}
Kostenlos starten →